Cardiac Implants
Press Release: St. Jude Medical receives CE Mark approval for pacing lead labeling that will expand patient access to MRI scans
St. Jude chases MRI-friendly labeling for its CRM devices
St. Jude cries victory with its quadripolar leads
Medical device giant St. Jude Medical (NYSE:STJ) had high praise for its own quadripolar leads, saying that blow away any competition from older bipolar leads.
Pacemakers learn from wristwatches to ditch batteries
Swiss researchers are taking a page from their country’s most iconic products to change how pacemakers are powered inside the body.
Medtronic launches personalized heart rhythm therapy trial
Boston Scientific lands another date with FDA panel for Watchman stroke device
Occlutech claims another win over St. Jude Medical
Valve-in-valve surgery shows promise in new registry study
New research released this week provides more support for the use of transcatheter aortic valve-in-valve (VIV) implantation as a means of replacing previously implanted valves that have deteriorated over time.
More good news for Abbott’s MitraClip in JACC study
DC Devices secures another $34M for transcatheter cardiac shunt
Bay State startup DC Device announced the successful close of a $34 million Series D financing round, hoping to use the funds to advance clinical evaluation of its InterAtrial Shunt Device.
The company aims to market the world’s 1st minimally invasive device for treating diastolic heart failure, a market worth a potential $5 billion globally, according to a DC Device press release.